These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33561783)

  • 1. A multimodal molecular imaging approach targeting urokinase plasminogen activator receptor for the diagnosis, resection and surveillance of urothelial cell carcinoma.
    Baart VM; van der Horst G; Deken MM; Bhairosingh SS; Schomann T; Sier VQ; van der Mark MH; Iamele L; de Jonge H; Resnati M; Mazar AP; Pelger RCM; van der Pluijm G; Kuppen PJK; Vahrmeijer AL; Sier CFM
    Eur J Cancer; 2021 Mar; 146():11-20. PubMed ID: 33561783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors.
    Baart VM; van Manen L; Bhairosingh SS; Vuijk FA; Iamele L; de Jonge H; Scotti C; Resnati M; Cordfunke RA; Kuppen PJK; Mazar AP; Burggraaf J; Vahrmeijer AL; Sier CFM
    Mol Imaging Biol; 2023 Feb; 25(1):122-132. PubMed ID: 34642899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.
    Christensen A; Juhl K; Persson M; Charabi BW; Mortensen J; Kiss K; Lelkaitis G; Rubek N; von Buchwald C; Kjær A
    Oncotarget; 2017 Feb; 8(9):15407-15419. PubMed ID: 28039488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts.
    Kurbegovic S; Juhl K; Sørensen KK; Leth J; Willemoe GL; Christensen A; Adams Y; Jensen AR; von Buchwald C; Skjøth-Rasmussen J; Ploug M; Jensen KJ; Kjaer A
    Theranostics; 2021; 11(15):7159-7174. PubMed ID: 34158842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery.
    Tang C; Du Y; Liang Q; Cheng Z; Tian J
    Mol Imaging Biol; 2020 Jun; 22(3):476-485. PubMed ID: 31228075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Targeted NIR-II Probe for Image-Guided Brain Tumor Surgery.
    Kurbegovic S; Juhl K; Chen H; Qu C; Ding B; Leth JM; Drzewiecki KT; Kjaer A; Cheng Z
    Bioconjug Chem; 2018 Nov; 29(11):3833-3840. PubMed ID: 30296054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery.
    Boonstra MC; van Driel PB; van Willigen DM; Stammes MA; Prevoo HA; Tummers QR; Mazar AP; Beekman FJ; Kuppen PJ; van de Velde CJ; Löwik CW; Frangioni JV; van Leeuwen FW; Sier CF; Vahrmeijer AL
    Oncotarget; 2015 Jun; 6(16):14260-73. PubMed ID: 25895028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting uPAR with antagonistic recombinant human antibodies in aggressive breast cancer.
    LeBeau AM; Duriseti S; Murphy ST; Pepin F; Hann B; Gray JW; VanBrocklin HF; Craik CS
    Cancer Res; 2013 Apr; 73(7):2070-81. PubMed ID: 23400595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.
    Hekman MCH; Boerman OC; Bos DL; Massuger LFAG; Weil S; Grasso L; Rybinski KA; Oosterwijk E; Mulders PFA; Rijpkema M
    Mol Pharm; 2017 Oct; 14(10):3457-3463. PubMed ID: 28826214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EpCAM as multi-tumour target for near-infrared fluorescence guided surgery.
    van Driel PB; Boonstra MC; Prevoo HA; van de Giessen M; Snoeks TJ; Tummers QR; Keereweer S; Cordfunke RA; Fish A; van Eendenburg JD; Lelieveldt BP; Dijkstra J; van de Velde CJ; Kuppen PJ; Vahrmeijer AL; Löwik CW; Sier CF
    BMC Cancer; 2016 Nov; 16(1):884. PubMed ID: 27842504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
    Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
    J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and Characterization of Novel Pan-Cancer Anti-uPAR Fluorescent Nanobodies as Tools for Image-Guided Surgery.
    Mateusiak Ł; Floru S; De Groof TWM; Wouters J; Declerck NB; Debie P; Janssen S; Zeven K; Puttemans J; Vincke C; Breckpot K; Devoogdt N; Hernot S
    Adv Sci (Weinh); 2024 Aug; 11(30):e2400700. PubMed ID: 38845188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DOT corrected fluorescence molecular tomography using targeted contrast agents for small animal tumor imaging.
    Tan Y; Cao Z; Sajja HK; Lipowska M; Wang YA; Yang L; Jiang H
    J Xray Sci Technol; 2013; 21(1):43-52. PubMed ID: 23507851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved resection and prolonged overall survival with PD-1-IRDye800CW fluorescence probe-guided surgery and PD-1 adjuvant immunotherapy in 4T1 mouse model.
    Du Y; Sun T; Liang X; Li Y; Jin Z; Xue H; Wan Y; Tian J
    Int J Nanomedicine; 2017; 12():8337-8351. PubMed ID: 29200846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver.
    Van Buren G; Gray MJ; Dallas NA; Xia L; Lim SJ; Fan F; Mazar AP; Ellis LM
    Cancer; 2009 Jul; 115(14):3360-8. PubMed ID: 19484792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.
    Yang L; Sajja HK; Cao Z; Qian W; Bender L; Marcus AI; Lipowska M; Wood WC; Wang YA
    Theranostics; 2013; 4(1):106-18. PubMed ID: 24396518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate cancer invasion, migration, growth, and experimental skeletal metastasis in vitro and in vivo.
    Rabbani SA; Ateeq B; Arakelian A; Valentino ML; Shaw DE; Dauffenbach LM; Kerfoot CA; Mazar AP
    Neoplasia; 2010 Oct; 12(10):778-88. PubMed ID: 20927316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NIR-II fluorescence imaging-guided colorectal cancer surgery targeting CEACAM5 by a nanobody.
    Guo X; Li C; Jia X; Qu Y; Li M; Cao C; Zhang Z; Qu Q; Luo S; Tang J; Liu H; Hu Z; Tian J
    EBioMedicine; 2023 Mar; 89():104476. PubMed ID: 36801616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer.
    Marston JC; Kennedy GD; Lapi SE; Hartman YE; Richardson MT; Modi HM; Warram JM
    J Surg Res; 2019 Jul; 239():44-51. PubMed ID: 30798171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.